Trials / Unknown
UnknownNCT02367404
Prospective RCT on Post Prostatectomy Urine Leak
A Prospective Randomized Controlled Study Comparing the Efficacy of Pelvic Floor Muscle Training and Oral Duloxetine in the Recovery of Continence After Robotic Assisted Radical Prostatectomy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Institut Mutualiste Montsouris · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Objectives: Primary: Comparison of proportion of patient achieving continence between the four arms at 6 months. Secondary: * Comparison of time to achieve continence between the four arms. * Comparison of urinary symptoms and quality of life improvement between the four arms. * Assessment of adverse events in Duloxetine arms. Primary outcome/ time frame: Proportion of patient achieving continence at 6 months. Continence is defined as "using no pad"or "only security pad". Secondary outcome: * time to achieve continence * Quality of life tested in relation to incontinence according to Visual Analog Scale (VAS) and King's Health Questionnaire (KQH). * Urinary symptoms measured with International Prostate Symptom Score (IPSS). No. of subjects entered: 300 patients informed and included, 240 patients will be randomized. Statistical methods * Proportion of patients who achieve continence and time to achieve continence will be compared between the four arms. * Comparison of quality of life outcomes between the four arms * Comparison of clinical variables that can affect the primary/secondary outcome - univariate and multivariate analysis (ITT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Duloxetine 60mg OD for 3 months |
| BEHAVIORAL | Pelvic Floor Muscle Training | PMFT weekly for 3 months |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-02-01
- Completion
- 2017-06-01
- First posted
- 2015-02-20
- Last updated
- 2016-09-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02367404. Inclusion in this directory is not an endorsement.